may health logo

May Health Appoints Seasoned Medtech Executive, Colby Holtshouse, as President and CEO

//
Categories

Leadership transition comes as Company focuses on clinical evaluation of its novel Ovarian Rebalancing™ technology, a one-time transvaginal ablation procedure designed to restore ovulation in women with PCOS, a leading cause of infertility

PARIS, March 10, 2025 /PRNewswire/ — May Health, a Paris- and California-based, clinical-stage medical device company dedicated to the development of a new treatment for Polycystic Ovary Syndrome (PCOS), today announced that Colby Holtshouse has joined the Company as President and CEO. Colby brings a wealth of senior leadership and women’s health expertise to the organization, having held executive positions with Organon (NYSE: OGN), Alydia Health, and Pelvalon.

Read More